Advertisement
CeriBell, Inc.

CeriBell, Inc. Fundamental Analysis

CBLLNASDAQ
HealthcareMedical - Devices
$18.34
$0.20(1.13%)
U.S. Market is Open · 13:35
Advertisement

CeriBell, Inc. Fundamental Analysis

CeriBell, Inc. (CBLL) shows weak financial fundamentals with a PE ratio of -11.47, profit margin of -63.51%, and ROE of -38.19%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position20.26%
PEG Ratio-0.42
Current Ratio10.30

Areas of Concern

ROE-38.19%
Operating Margin-68.31%
We analyze CBLL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -74.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-74.2/100

We analyze CBLL's fundamental strength across five key dimensions:

Efficiency Score

Weak

CBLL struggles to generate sufficient returns from assets.

ROA > 10%
-33.90%

Valuation Score

Excellent

CBLL trades at attractive valuation levels.

PE < 25
-11.47
PEG Ratio < 2
-0.42

Growth Score

Weak

CBLL faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

CBLL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.16
Current Ratio > 1
10.30

Profitability Score

Weak

CBLL struggles to sustain strong margins.

ROE > 15%
-3818.69%
Net Margin ≥ 15%
-63.51%
Positive Free Cash Flow
No

Key Financial Metrics

Is CBLL Expensive or Cheap?

P/E Ratio

CBLL trades at -11.47 times earnings. This suggests potential undervaluation.

-11.47

PEG Ratio

When adjusting for growth, CBLL's PEG of -0.42 indicates potential undervaluation.

-0.42

Price to Book

The market values CeriBell, Inc. at 4.92 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.92

EV/EBITDA

Enterprise value stands at -12.16 times EBITDA. This is generally considered low.

-12.16

How Well Does CBLL Make Money?

Net Profit Margin

For every $100 in sales, CeriBell, Inc. keeps $-63.51 as profit after all expenses.

-63.51%

Operating Margin

Core operations generate -68.31 in profit for every $100 in revenue, before interest and taxes.

-68.31%

ROE

Management delivers $-38.19 in profit for every $100 of shareholder equity.

-38.19%

ROA

CeriBell, Inc. generates $-33.90 in profit for every $100 in assets, demonstrating efficient asset deployment.

-33.90%

Following the Money - Real Cash Generation

Operating Cash Flow

CeriBell, Inc. generates limited operating cash flow of $-49.21M, signaling weaker underlying cash strength.

$-49.21M

Free Cash Flow

CeriBell, Inc. generates weak or negative free cash flow of $-49.96M, restricting financial flexibility.

$-49.96M

FCF Per Share

Each share generates $-1.32 in free cash annually.

$-1.32

FCF Yield

CBLL converts -7.11% of its market value into free cash.

-7.11%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-11.47

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.42

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.92

vs 25 benchmark

P/S Ratio

Price to sales ratio

7.34

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.16

vs 25 benchmark

Current Ratio

Current assets to current liabilities

10.30

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.38

vs 25 benchmark

ROA

Return on assets percentage

-0.34

vs 25 benchmark

ROCE

Return on capital employed

-0.40

vs 25 benchmark

How CBLL Stacks Against Its Sector Peers

MetricCBLL ValueSector AveragePerformance
P/E Ratio-11.4734.27 Better (Cheaper)
ROE-38.19%377.00% Weak
Net Margin-63.51%-42945.00% (disorted) Weak
Debt/Equity0.160.78 Strong (Low Leverage)
Current Ratio10.305.54 Strong Liquidity
ROA-33.90%-162.00% (disorted) Weak

CBLL outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews CeriBell, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ